Citation:Van Hazel GA, Heinemann V, Sharma NK, Findlay MP, Ricke J, Peeters M, et al 2016
From Cancer Guidelines Wiki
Citation
van Hazel GA, Heinemann V, Sharma NK, Findlay MP, Ricke J, Peeters M, et al. SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer. J Clin Oncol 2016 May 20;34(15):1723-31 Available from: http://www.ncbi.nlm.nih.gov/pubmed/26903575.
Critical appraisals
Compare quality appraisals for each clinical question
- [[Clinical question:Liver directed therapies unresectable metastatic CRC|Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Liver directed therapies unresectable metastatic CRC</span></span></span>»]] (compare critical appraisals)
- [[Clinical question:Liver directed therapies unresectable metastatic CRC|Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Liver directed therapies unresectable metastatic CRC</span></span></span></span>»]] (compare critical appraisals)